1. Home
  2. UPBD vs PHAT Comparison

UPBD vs PHAT Comparison

Compare UPBD & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$19.81

Market Cap

1.2B

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$12.23

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPBD
PHAT
Founded
1986
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
UPBD
PHAT
Price
$19.81
$12.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$32.25
$17.33
AVG Volume (30 Days)
631.5K
988.1K
Earning Date
02-19-2026
03-05-2026
Dividend Yield
7.62%
N/A
EPS Growth
N/A
N/A
EPS
1.45
N/A
Revenue
$4,577,844,000.00
$147,190,000.00
Revenue This Year
$10.33
$221.87
Revenue Next Year
$7.55
$80.37
P/E Ratio
$14.11
N/A
Revenue Growth
7.48
460.30
52 Week Low
$15.82
$2.21
52 Week High
$30.20
$18.31

Technical Indicators

Market Signals
Indicator
UPBD
PHAT
Relative Strength Index (RSI) 52.73 35.59
Support Level $19.40 $12.22
Resistance Level $20.84 $13.18
Average True Range (ATR) 0.74 0.80
MACD 0.04 -0.10
Stochastic Oscillator 54.62 7.91

Price Performance

Historical Comparison
UPBD
PHAT

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: